(Updated - August 19, 2026 7:00 AM EDT)

Wedbush analyst David Nierengarten initiates coverage on Aktis Oncology (NASDAQ: AKTS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE